|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Atherosclerosis | |||||
| Postmenopause | |||||
| 2 | More general conditions related to this trial | ||||
| Arterial Occlusive Diseases | |||||
| Arteriosclerosis | |||||
| Cardiovascular Diseases | |||||
| Vascular Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| Micronized 17B-estradiol | |||||
| 4 | Sponsors listed in this trial | ||||
| National Institute on Aging (NIA) | |||||
| Mead Johnson | |||||